Body Contouring Outcomes: GLP-1 Weight Loss vs. Bariatric Surgery

The rise of GLP-1 receptor agonists (GLP-1 RAs) like semaglutide and tirzepatide has revolutionized medical weight management, offering significant weight loss comparable to some bariatric surgeries. However, substantial weight loss, regardless of method, often leads to excess skin, necessitating body contouring surgery to improve functional and aesthetic outcomes. There's a critical need to understand how surgical outcomes for body contouring differ between patients who achieve weight loss through GLP-1 RAs versus bariatric surgery.

The study revealed notable differences in post-operative complications. Overall minor complication rates were 18.5% in the GLP-1 RA group compared to 23.1% in the bariatric surgery group (p=0.04). Specifically, the incidence of seroma (fluid accumulation) was 7.2% in GLP-1 RA patients versus 10.5% in bariatric surgery patients (p=0.03), and wound dehiscence (wound separation) was 3.8% vs 5.9% (p=0.08). Major complication rates, including infection requiring re-admission or hematoma requiring surgical evacuation, were statistically similar between groups (4.1% vs 5.3%, p=0.32). Revision surgery rates were also comparable, with 12.0% for GLP-1 RA patients and 14.5% for bariatric surgery patients (p=0.21). Patient satisfaction scores, assessed via a validated questionnaire at 12 months post-surgery, showed no statistically significant difference between groups (p=0.15), with both cohorts reporting high satisfaction (mean score 4.2/5 vs 4.1/5).